Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer.
The genome is organized and packed into the nucleus through interactions with core histone proteins. Emerging evidence suggests that tumors are highly responsive to epigenetic alterations that induce chromatin-based events and dynamically influence tumor behavior. We examined chromatin organization...
Main Authors: | Fernanda S Giudice, Decio S Pinto, Jacques E Nör, Cristiane H Squarize, Rogerio M Castilho |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3603970?pdf=render |
Similar Items
-
Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells.
by: Dejuan Kong, et al.
Published: (2012-01-01) -
A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer.
by: Takuya Sakamoto, et al.
Published: (2016-01-01) -
Epithelial-to-Mesenchymal Transition in the Pathogenesis and Therapy of Head and Neck Cancer
by: Julia Thierauf, et al.
Published: (2017-07-01) -
The translational significance of epithelial‐mesenchymal transition in head and neck cancer
by: Christian A Graves, et al.
Published: (2014-12-01) -
Profiling the Behavior of Distinct Populations of Head and Neck Cancer Stem Cells
by: Luciana O. Almeida, et al.
Published: (2016-01-01)